Distinct Healthcare Hldg Ltd (2677) Fair Value & Analysis
Healthcare · HK · Market cap HK$1.9B
Fair value as of: Aug 13, 2026
From 21 valuation models · updated 3 days ago
Fair value updated Aug 13, 2026, revised from HK$41.31 to HK$41.35 (+0.1%) since Aug 6, 2026. Share price −10.1% over the past month.
A solid business, screening 62% undervalued on our models.
What matters now
- The price is below even our cautious bear case (HK$31.01). The market is more pessimistic than our downside scenario.
- Solid quality (64/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (6 months)
White line = price, green steps = our fair value per fiscal year. As of Aug 13, 2026.
How to read this chart
6‑month range HK$21.04 – HK$67.90 · fair‑value band HK$31.01 – HK$51.69 · the HK$25.46 price screens below the HK$41.35 fair value. As of Aug 13, 2026.
Analysis
Distinct Healthcare Hldg Ltd (2677) currently trades at HK$25.46, while our model-based Fair Value estimate is HK$41.35, implying the stock looks roughly 62.4% undervalued today. The Quality Score stands at 64/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Distinct Healthcare Hldg Ltd generated revenue of HK$1.1B at a net margin of 12.7%. The stock trades on a trailing P/E of 12.1 (as of Jul 2, 2026). Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$31.01 (bear case) to HK$51.69 (bull case); at HK$25.46, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 72% below its 52-week high and 27% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at 62%, 2677 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 21 models by family
Widest divergence: Growth Earnings (HK$59.97) versus Economic Profit (HK$8.41). Highest evidence: Growth DCF (72).
Notify me when 2677 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 63 · Market factors (momentum, volatility) 18
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Distinct Healthcare Holdings Limited operates as a healthcare service provider in China. The company offers medical services in the areas of pediatrics, dentistry, eye care, dermatology, ear, nose and throat, general surgery, women's health, physical therapy and rehabilitation, psychiatry and psychology, and internal healthcare.
Full company description
Distinct Healthcare Holdings Limited operates as a healthcare service provider in China. The company offers medical services in the areas of pediatrics, dentistry, eye care, dermatology, ear, nose and throat, general surgery, women's health, physical therapy and rehabilitation, psychiatry and psychology, and internal healthcare. It provides professional healthcare services that cover a range of specialties through its private healthcare service institutions and tele-healthcare service platform. The company operates through its brand name and its tele-healthcare service platform, Distinct HealthCare. The company's platforms include Hospital Management System ("HMS"), Distinct Management System ("DMS") and Distinct Data Platform. Its platform HMS is a cloud-based electronic medical record system; DMS is a comprehensive patient management system to streamline and standardize the process of patient management and its Distinct Data Platform aggregates all data from different realms such as user background and activity data, anonymized clinical data, operation data and financial data. Distinct HealthCare has a strategic partnership with Tencent Holdings Limited. Distinct Healthcare Holdings Limited was founded in 2012 and is based in Shenzhen, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Distinct Healthcare Hldg Ltd reported revenue of HK$1.1B in FY2025 versus HK$473M in FY2022, a compound +31.0%/yr. Reported net income was HK$135M in FY2025.
Watch 2677: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 266 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $414.59 | $547.67 | +32% |
| Fresenius SE FRE | €46.82 | €32.15 | -31% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | -46% |
| Tenet Healthcare Corporation THC | $266.79 | $330.25 | +24% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.97 | R$47.31 | +39% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,565 | ₹2,955 | -65% |
| Aier Eye Hospital Group 300015 | ¥8.87 | ¥7.67 | -14% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,008 | ₹284.87 | -72% |
| Bangkok Dusit Medical Services Public Company BDMS | 19.70 THB | 18.57 THB | -6% |
Compare Distinct Healthcare Hldg Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Distinct Healthcare Hldg Ltd (2677) overvalued or undervalued?
What is the fair value of 2677?
What is the quality score of 2677?
What is the revenue of Distinct Healthcare Hldg Ltd (2677)?
What is the net profit margin of 2677?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Distinct Healthcare Hldg Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.